Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at 24 weeks: A Posthoc Analysis from ENLIVEN

Saved in:
Bibliographic Details
Published in:Metabolism, clinical and experimental clinical and experimental, 2024-06, Vol.153, p.155874, Article 155874
Main Authors: Loomba, Rohit, Sanyal, Arun J., Gottwald, Mildred D., Feng, Shibao, Tseng, Leo, Hartsfield, Cynthia L., Mansbach, Hank, Margalit, Maya, Bhatt, Deepak L.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0026-0495
DOI:10.1016/j.metabol.2024.155874